GEVA Related New Coverage

Jan 2, 2013 05:53 PM Janney Montgomery Scott Starts Synageva BioPharma (GEVA) at Neutral

Sep 5, 2012 05:21 PM Piper Jaffray Starts Synageva BioPharma (GEVA) at Overweight

Jun 29, 2012 08:26 AM ThinkEquity Starts Synageva BioPharma (GEVA) at Buy

Jun 25, 2012 08:20 AM UPDATE: Canaccord Genuity Starts Synageva BioPharma (GEVA) at Buy; Attractive Orphan Platform

Apr 20, 2012 08:07 AM Morgan Stanley Starts Synageva BioPharma (GEVA) at Overweight

Feb 29, 2012 07:57 AM JPMorgan Starts Synageva BioPharma (GEVA) at Overweight, Sets $50 Price Target

Jan 30, 2012 09:20 AM Cowen Starts Synageva BioPharma (GEVA) at Outperform

Jan 17, 2012 07:19 AM Leerink Swann Starts Synageva BioPharma (GEVA) at Market Perform

Dec 13, 2011 07:04 AM Wedbush Starts Synageva BioPharma (GEVA) at Outperform; Focused on Rare Diseases With Its Golden Eggs